Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center
暂无分享，去创建一个
Alexandra R Sowa | Isaac M Jackson | Timothy J Desmond | Jeremiah Alicea | Anthony J Mufarreh | Jonathan M Pham | Jenelle Stauff | Wade P Winton | Maria V Fawaz | Bradford D Henderson | Brian G Hockley | Virginia E Rogers | Robert A Koeppe | Peter J H Scott | Bradford D. Henderson | R. Koeppe | P. Scott | Wade P. Winton | T. Desmond | B. Hockley | J. Stauff | Jonathan M. Pham | Jeremiah Alicea | Anthony J. Mufarreh | Isaac M. Jackson | Maria V. Fawaz
[1] Stephen Thompson,et al. Radiochemistry, PET Imaging, and the Internet of Chemical Things , 2016, ACS central science.
[2] John M Hoffman,et al. Regulatory Requirements for PET Drug Production , 2014, The Journal of Nuclear Medicine.
[3] P. Scott,et al. Synthesis of [18F]‐Fluorodeoxyglucose ([18F]FDG) , 2012 .
[4] S. Yu,et al. Review of 18F-FDG Synthesis and Quality Control , 2006, Biomedical Imaging and Intervention Journal.
[5] 山田 哲. Changes to an Approved NDA or ANDA Revision 1の解説・全訳 , 2004 .